Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
GnRH agonist
DRUG CLASS:
GnRH agonist
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
leuprolide acetate (14)
triptorelin (9)
goserelin acetate (7)
histrelin acetate (5)
leuprolide 6-month depot (1)
leuprorelin depot (1)
leuprolide acetate for depot suspension (1)
buserelin acetate (0)
leuprolide acetate (14)
triptorelin (9)
goserelin acetate (7)
histrelin acetate (5)
leuprolide 6-month depot (1)
leuprorelin depot (1)
leuprolide acetate for depot suspension (1)
buserelin acetate (0)
›
Associations
(39)
News
Trials
Phase
Status
Apply
Phase
Status
Apply
Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer (OVELIA) (NCT04906395)
Phase 3
Tolmar Inc.
Tolmar Inc.
Recruiting
Phase 3
Tolmar Inc.
Recruiting
Last update posted :
02/24/2025
Initiation :
07/01/2021
Primary completion :
04/30/2026
Completion :
04/30/2026
HER-2
|
HER-2 negative
|
tamoxifen • letrozole • anastrozole • exemestane • Eligard (leuprolide acetate)
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer (EVANGELINE) (NCT05607004)
Phase 2
Atossa Therapeutics, Inc.
Atossa Therapeutics, Inc.
Recruiting
Phase 2
Atossa Therapeutics, Inc.
Recruiting
Last update posted :
02/24/2025
Initiation :
02/14/2023
Primary completion :
02/01/2026
Completion :
09/01/2026
HER-2 • ER
|
HER-2 negative
|
exemestane • goserelin acetate
Testing the Anti-Cancer Drug Darolutamide in Patients With Testosterone-driven Salivary Gland Cancers (NCT05669664)
Phase 2
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Recruiting
Phase 2
National Cancer Institute (NCI)
Recruiting
Last update posted :
02/12/2025
Initiation :
07/20/2023
Primary completion :
04/11/2027
Completion :
04/11/2027
AR
|
AR positive
|
Eligard (leuprolide acetate) • Nubeqa (darolutamide) • Viadur (leuprorelin implant)
A Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland Carcinoma (YATAGARASU) (NCT04325828)
Phase 2
Janssen Pharmaceutical K.K.
Janssen Pharmaceutical K.K.
Active, not recruiting
Phase 2
Janssen Pharmaceutical K.K.
Active, not recruiting
Last update posted :
02/10/2025
Initiation :
04/07/2020
Primary completion :
06/09/2021
Completion :
12/31/2027
AR
|
AR positive
|
apalutamide • goserelin acetate
Study of Quality of Life and Hormone Levels in Premenopausal Participants With Early Breast Cancer Receiving Triptorelin Plus Additional Cancer Treatment (ROSE) (NCT05377684)
Phase N/A
Ipsen
Ipsen
Active, not recruiting
Phase N/A
Ipsen
Active, not recruiting
Last update posted :
01/31/2025
Initiation :
06/09/2022
Primary completion :
06/30/2026
Completion :
06/30/2026
HER-2 • BRCA1 • BRCA2 • BRCA
|
HR positive • HER-2 negative • HR positive + HER-2 negative • BRCA mutation
|
triptorelin
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer (S1802) (NCT03678025)
Phase 3
SWOG Cancer Research Network
SWOG Cancer Research Network
Recruiting
Phase 3
SWOG Cancer Research Network
Recruiting
Last update posted :
08/16/2024
Initiation :
09/24/2018
Primary completion :
04/01/2028
Completion :
10/01/2031
SYP
|
docetaxel • abiraterone acetate • prednisone • Eligard (leuprolide acetate) • bicalutamide • triptorelin • goserelin acetate • flutamide • nilutamide • Firmagon (degarelix) • Viadur (leuprorelin implant)
Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors (NRG-GY033) (NCT06169124)
Phase 2
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Suspended
Phase 2
National Cancer Institute (NCI)
Suspended
Last update posted :
06/10/2024
Initiation :
02/08/2024
Primary completion :
05/31/2027
Completion :
05/31/2027
ER • PGR
|
exemestane • Eligard (leuprolide acetate) • Nubeqa (darolutamide) • Viadur (leuprorelin implant)
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial (NCT04513717)
Phase 3
NRG Oncology
NRG Oncology
Recruiting
Phase 3
NRG Oncology
Recruiting
Last update posted :
02/07/2024
Initiation :
12/15/2020
Primary completion :
12/31/2033
Completion :
12/31/2033
CD4
|
abiraterone acetate • bicalutamide • apalutamide • triptorelin • goserelin acetate • flutamide • Firmagon (degarelix) • leuprolide acetate for depot suspension • Suprefact (buserelin acetate) • Yonsa (abiraterone acetate)
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer (TEXT) (NCT00066703)
Phase 3
ETOP IBCSG Partners Foundation
ETOP IBCSG Partners Foundation
Active, not recruiting
Phase 3
ETOP IBCSG Partners Foundation
Active, not recruiting
Last update posted :
01/01/2024
Initiation :
11/03/2003
Primary completion :
03/11/2011
Completion :
12/01/2025
PGR
|
HR positive • PGR positive
|
tamoxifen • exemestane • triptorelin
The Benefits of Continued Use of Ovarian Function Suppression After 5 Years (NCT06050109)
Phase N/A
Hongmei Zheng
Hongmei Zheng
Recruiting
Phase N/A
Hongmei Zheng
Recruiting
Last update posted :
10/11/2023
Initiation :
09/01/2023
Primary completion :
09/01/2028
Completion :
09/01/2028
HER-2
|
HER-2 positive • HR positive • HER-2 negative • HR positive + HER-2 negative
|
goserelin acetate
Tracer-Guided Surgery for Recurrent Prostate Cancer (Trace-II) (NCT05555017)
Phase 2
The Netherlands Cancer Institute
The Netherlands Cancer Institute
Recruiting
Phase 2
The Netherlands Cancer Institute
Recruiting
Last update posted :
10/06/2023
Initiation :
02/15/2023
Primary completion :
11/01/2024
Completion :
11/01/2025
FOLH1
|
FOLH1 expression
|
triptorelin
A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer (ASCLEPIuS) (NCT04194554)
Phase 1/2
University of Michigan Rogel Cancer Center
University of Michigan Rogel Cancer Center
Recruiting
Phase 1/2
University of Michigan Rogel Cancer Center
Recruiting
Last update posted :
09/14/2023
Initiation :
11/06/2020
Primary completion :
11/01/2026
Completion :
05/01/2027
DRD
|
DDR • DRD
|
Zejula (niraparib) • abiraterone acetate • leuprolide acetate for depot suspension
Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients (NCT06009627)
Phase 2/3
Tianjin Medical University Cancer Institute and Hospital
Tianjin Medical University Cancer Insti...
Recruiting
Phase 2/3
Tianjin Medical University Cancer Institute and...
Recruiting
Last update posted :
08/24/2023
Initiation :
04/11/2023
Primary completion :
03/11/2025
Completion :
09/11/2026
HER-2 • ER
|
ER positive • HER-2 negative • HER-2 expression • PGR expression
|
cyclophosphamide • epirubicin • exemestane • goserelin acetate
Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer (NCT05945407)
Phase N/A
Peking University People's Hospital
Peking University People's Hospital
Recruiting
Phase N/A
Peking University People's Hospital
Recruiting
Last update posted :
07/14/2023
Initiation :
08/01/2016
Primary completion :
12/31/2023
Completion :
12/31/2027
TP53 • PTEN • MLH1 • MSH6 • MSH2
|
TP53 expression
|
triptorelin • goserelin acetate • megestrol
Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02 (TEXT-Bone) (NCT00963417)
Phase N/A
ETOP IBCSG Partners Foundation
ETOP IBCSG Partners Foundation
Active, not recruiting
Phase N/A
ETOP IBCSG Partners Foundation
Active, not recruiting
Last update posted :
05/31/2023
Initiation :
08/03/2009
Primary completion :
03/11/2011
Completion :
12/01/2025
IGF1 • IGFBP3
|
HR positive
|
tamoxifen • exemestane • triptorelin
OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk (INTERSTELLAR) (NCT05333328)
Phase 4
Gangnam Severance Hospital
Gangnam Severance Hospital
Recruiting
Phase 4
Gangnam Severance Hospital
Recruiting
Last update posted :
02/09/2023
Initiation :
02/06/2023
Primary completion :
01/01/2028
Completion :
01/01/2033
HER-2 • ER
|
HER-2 negative
|
tamoxifen • goserelin acetate
Safety of OFS Combined With AI Endocrine Therapy in Chinese Premenopausal Breast Cancer Patients (SEAT) (NCT02440230)
Phase 2
Shanghai Jiao Tong University School of Medicine
Shanghai Jiao Tong University School of...
Completed
Phase 2
Shanghai Jiao Tong University School of Medicine
Completed
Last update posted :
12/30/2022
Initiation :
05/01/2015
Primary completion :
12/01/2021
Completion :
12/01/2021
ER • PGR
|
anastrozole • exemestane • goserelin acetate
Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer (NCT02535221)
Phase 3
Peking University
Peking University
Recruiting
Phase 3
Peking University
Recruiting
Last update posted :
11/29/2021
Initiation :
07/29/2015
Primary completion :
06/30/2026
Completion :
12/31/2026
HER-2 • PGR
|
HER-2 negative • PGR positive
|
epirubicin • goserelin acetate
RWE About QOL and Compliance of Patients With OFS in China (NCT05122377)
Phase N/A
Fudan University
Fudan University
Not yet recruiting
Phase N/A
Fudan University
Not yet recruiting
Last update posted :
11/16/2021
Initiation :
11/01/2021
Primary completion :
02/01/2024
Completion :
04/01/2024
HER-2
|
HER-2 negative
|
goserelin acetate • leuprolide acetate for depot suspension
Study of Estrogen Levels in Premenopausal Women Who Have Undergone Surgery for Breast Cancer and Are Receiving Triptorelin and Tamoxifen Citrate or Exemestane on Clinical Trial IBCSG 24-02 (SOFT-EST) (NCT00975676)
Phase N/A
ETOP IBCSG Partners Foundation
ETOP IBCSG Partners Foundation
Completed
Phase N/A
ETOP IBCSG Partners Foundation
Completed
Last update posted :
10/25/2021
Initiation :
11/25/2008
Primary completion :
12/01/2016
Completion :
12/01/2016
ER • PGR
|
PGR positive
|
tamoxifen • exemestane • triptorelin • Soltamox (tamoxifen citrate)
Efficacy and Safety of Leuprorelin 3M in Premenopausal Women With Hormone Receptor-positive Breast Cancer (NCT04891731)
Phase N/A
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sun Yat-Sen Memorial Hospital of Sun Ya...
Not yet recruiting
Phase N/A
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen Un...
Not yet recruiting
Last update posted :
05/18/2021
Initiation :
05/01/2021
Primary completion :
05/01/2023
Completion :
09/01/2023
ER
|
PGR expression
|
tamoxifen • exemestane • leuprolide acetate for depot suspension
To Compare ZOLADEX 10.8 mg With ZOLADEX 3.6mg in Chinese Pre-menopausal ER+ HER2- Early Breast Cancer. (LARES) (NCT03658213)
Phase 3
AstraZeneca
AstraZeneca
Withdrawn
Phase 3
AstraZeneca
Withdrawn
Last update posted :
05/10/2021
Initiation :
03/31/2020
Primary completion :
11/04/2021
Completion :
11/04/2021
HER-2 • ER
|
HER-2 negative
|
goserelin acetate
Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation (NCT01338987)
Phase 2
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Completed
Phase 2
National Cancer Institute (NCI)
Completed
Last update posted :
03/18/2021
Initiation :
04/19/2011
Primary completion :
12/01/2017
Completion :
11/19/2020
FLT3 • ABL1 • BCR • KMT2A • HLA-DRB1 • HLA-B • HLA-C
|
MLL rearrangement • MLL rearrangement
|
cyclophosphamide • methotrexate • fludarabine IV • busulfan • leuprolide acetate for depot suspension • cyclophosphamide intravenous
Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer (NCT00970203)
Phase 2
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Completed
Phase 2
Roswell Park Cancer Institute
Completed
Last update posted :
11/03/2020
Initiation :
09/01/2009
Primary completion :
10/05/2018
Completion :
10/05/2019
CD8 • CD4
|
HLA-A2 positive
|
goserelin acetate
S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer (NCT00068601)
Phase 3
Southwest Oncology Group
Southwest Oncology Group
Completed
Phase 3
Southwest Oncology Group
Completed
Last update posted :
12/30/2019
Initiation :
10/01/2003
Primary completion :
01/01/2014
Completion :
09/01/2016
ER • PGR
|
ER negative • PGR negative
|
cyclophosphamide • goserelin acetate
Melanoma Vaccine With Peptides and Leuprolide (NCT00254397)
Phase 2
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Completed
Phase 2
M.D. Anderson Cancer Center
Completed
Last update posted :
10/16/2019
Initiation :
11/01/2005
Primary completion :
10/01/2012
Completion :
10/01/2012
CD8
|
leuprolide acetate for depot suspension
Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women (NCT00186121)
Phase 2
Stanford University
Stanford University
Completed
Phase 2
Stanford University
Completed
Last update posted :
10/07/2019
Initiation :
10/01/2000
Primary completion :
05/01/2013
Completion :
06/01/2013
PGR
|
anastrozole • goserelin acetate
Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer (Triptocare) (NCT01020448)
Phase 3
Ipsen
Ipsen
Completed
Phase 3
Ipsen
Completed
Last update posted :
01/30/2019
Initiation :
11/01/2009
Primary completion :
11/01/2011
Completion :
06/01/2013
ERG • TMPRSS2 • PCA3
|
triptorelin
Study to Compare Zoladex™ 10.8 mg With Zoladex 3.6 mg in Pre-menopausal Women With Breast Cancer (NCT01073865)
Phase 3
AstraZeneca
AstraZeneca
Completed
Phase 3
AstraZeneca
Completed
Last update posted :
12/12/2018
Initiation :
02/26/2010
Primary completion :
09/19/2012
Completion :
11/20/2017
ER
|
ER positive
|
tamoxifen • goserelin acetate
Selective Treatment According to Molecular Subtype of Prostate Cancer (STAMP) (NCT03696186)
Phase 2
Tianjin Medical University Second Hospital
Tianjin Medical University Second Hospital
Recruiting
Phase 2
Tianjin Medical University Second Hospital
Recruiting
Last update posted :
10/09/2018
Initiation :
08/01/2018
Primary completion :
08/01/2022
Completion :
08/01/2023
BRAF
|
carboplatin • docetaxel • goserelin acetate
Neoadjuvant Goserelin for Triple Negative Breast Cancer (NeoGONT) (NCT03444025)
Phase 2
Kasr El Aini Hospital
Kasr El Aini Hospital
Not yet recruiting
Phase 2
Kasr El Aini Hospital
Not yet recruiting
Last update posted :
02/23/2018
Initiation :
03/01/2018
Primary completion :
03/01/2021
Completion :
03/01/2023
HER-2 • PGR • AR
|
HER-2 negative • AR positive • PGR negative
|
doxorubicin hydrochloride • cyclophosphamide • goserelin acetate
Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast Cancer (POF) (NCT02483767)
Phase 3
Peking Union Medical College Hospital
Peking Union Medical College Hospital
Completed
Phase 3
Peking Union Medical College Hospital
Completed
Last update posted :
10/17/2017
Initiation :
06/01/2015
Primary completion :
11/01/2016
Completion :
11/01/2016
HER-2
|
HER-2 overexpression
|
paclitaxel • cyclophosphamide • goserelin acetate
Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast Cancer (NCT01712893)
Phase 3
Fudan University
Fudan University
Completed
Phase 3
Fudan University
Completed
Last update posted :
08/25/2017
Initiation :
06/01/2009
Primary completion :
08/01/2017
Completion :
08/01/2017
ER • PGR
|
HR positive • ER negative • PGR positive • PGR expression
|
tamoxifen • goserelin acetate
The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient (NCT02588404)
Phase N/A
Sir Mortimer B. Davis - Jewish General Hospital
Sir Mortimer B. Davis - Jewish General ...
Not yet recruiting
Phase N/A
Sir Mortimer B. Davis - Jewish General Hospital
Not yet recruiting
Last update posted :
07/28/2016
Initiation :
12/01/2016
Primary completion :
01/01/2030
ERG • TMPRSS2
|
TMPRSS2-ERG fusion
|
Eligard (leuprolide acetate) • triptorelin • goserelin acetate • leuprolide acetate for depot suspension
Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer (NCT00010010)
Phase 2
NYU Langone Health
NYU Langone Health
Completed
Phase 2
NYU Langone Health
Completed
Last update posted :
03/11/2016
Initiation :
06/01/2000
Primary completion :
05/01/2001
PGR
|
ER positive + PGR positive • PGR positive
|
exemestane • goserelin acetate
Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer (NCT01530607)
Phase 3
King Faisal Specialist Hospital & Research Center
King Faisal Specialist Hospital & Resea...
Completed
Phase 3
King Faisal Specialist Hospital & Research Center
Completed
Last update posted :
02/25/2016
Initiation :
11/01/2009
Primary completion :
11/01/2012
Completion :
11/01/2012
PGR
|
ER negative • PGR negative
|
cyclophosphamide • goserelin acetate
A Phase 3 Comparative Study of TAP-144-SR(6M) in Postoperative and Hormone Therapy-naïve Patients With Premenopausal Breast Cancer (NCT01546649)
Phase 3
Takeda
Takeda
Completed
Phase 3
Takeda
Completed
Last update posted :
11/26/2015
Initiation :
04/01/2012
Primary completion :
12/01/2014
Completion :
12/01/2014
HER-2 • ER • PGR
|
ER positive • HER-2 negative
|
leuprolide acetate for depot suspension
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login